Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiliv Brenna

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 4, 2008
[Less hallway patients--give credit where credit is due]Eiliv Brenna
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2016
Eiliv Brenna
BMJ (Clinical Research Ed.)|February 23, 2002
Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biasedHelge L Waldum, Eiliv Brenna
Scandinavian Journal of Gastroenterology|March 14, 2007
pH 4.0Reidar Fossmark, Eiliv Brenna, Helge L Waldum
Expert Opinion on Drug Safety|August 9, 2003
Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infectionsHelge L Waldum, Eiliv Brenna, Arne K Sandvik
Scandinavian Journal of Gastroenterology|March 10, 2017
Chronic cholestatic liver diseasesHelge L Waldum, Einar S Björnsson, Eiliv Brenna
Gastroenterology|March 15, 2005
Nonulcer dyspepsia and proton pump inhibitorsHelge L Waldum, Tom Chr Martinsen, Eiliv Brenna
Scandinavian Journal of Gastroenterology|April 28, 2006
Capsule endoscopy in clinical routine in patients with suspected disease of the small intestine: a 2-year prospective studyGunnar Qvigstad, Peter Hatlen-Rebhan, Eiliv Brenna, et al.
Scandinavian Journal of Gastroenterology|February 14, 2016
Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?Helge L Waldum, Øyvind Hauso, Eiliv Brenna, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 19, 2008
Classification of tumoursHelge L Waldum, Arne K Sandvik, Eiliv Brenna, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 4, 2008
[Less hallway patients--give credit where credit is due]Eiliv Brenna
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2016
Eiliv Brenna
BMJ (Clinical Research Ed.)|February 23, 2002
Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biasedHelge L Waldum, Eiliv Brenna
Scandinavian Journal of Gastroenterology|March 14, 2007
pH 4.0Reidar Fossmark, Eiliv Brenna, Helge L Waldum
Expert Opinion on Drug Safety|August 9, 2003
Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infectionsHelge L Waldum, Eiliv Brenna, Arne K Sandvik
Scandinavian Journal of Gastroenterology|March 10, 2017
Chronic cholestatic liver diseasesHelge L Waldum, Einar S Björnsson, Eiliv Brenna
Gastroenterology|March 15, 2005
Nonulcer dyspepsia and proton pump inhibitorsHelge L Waldum, Tom Chr Martinsen, Eiliv Brenna
Scandinavian Journal of Gastroenterology|April 28, 2006
Capsule endoscopy in clinical routine in patients with suspected disease of the small intestine: a 2-year prospective studyGunnar Qvigstad, Peter Hatlen-Rebhan, Eiliv Brenna, et al.
Scandinavian Journal of Gastroenterology|February 14, 2016
Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?Helge L Waldum, Øyvind Hauso, Eiliv Brenna, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 19, 2008
Classification of tumoursHelge L Waldum, Arne K Sandvik, Eiliv Brenna, et al.
Pageof 2